These success, along with a earlier report exhibiting that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two support the strategy of targeting ACKR3 as a novel strategy to modulate the opioid system, which could open up new therapeutic avenues for opioid-linked disorders.Gene expression Evaluation discovered that